Alimera Sciences Inc. (ALIM)

1.25
NASDAQ : Health Technology
Prev Close 1.25
Day Low/High 0.00 / 0.00
52 Wk Low/High 1.03 / 1.72
Avg Volume 125.70K
Exchange NASDAQ
Shares Outstanding 69.15M
Market Cap 88.51M
EPS -0.60
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Alimera Sciences Announces 9 Clinical Presentations And A Sponsored Symposium At 17th Euretina Congress

Alimera Sciences Announces 9 Clinical Presentations And A Sponsored Symposium At 17th Euretina Congress

20 electronic posters available for review as well

Alimera Sciences Signs Agreement For Exclusive Distributor Of ILUVIEN® In France

Alimera Sciences Signs Agreement For Exclusive Distributor Of ILUVIEN® In France

Horus Pharma S.A.S. to also serve as agent in price negotiations with French Regulatory Authorities

Alimera Sciences Announces Italian Patients Now Being Treated With ILUVIEN®

Alimera Sciences Announces Italian Patients Now Being Treated With ILUVIEN®

ILUVIEN is fully reimbursable as a hospital-administered therapy in Italy

Alimera Sciences To Expand ILUVIEN® Indication In Europe For Posterior Uveitis

Alimera Sciences To Expand ILUVIEN® Indication In Europe For Posterior Uveitis

Signs license agreement with pSivida for posterior uveitis in Europe, the Middle East and Africa

TheStreet Quant Rating: D- (Sell)